Laurence Venat‐Bouvet
Hôpital Universitaire Dupuytren(FR)Hôpital Dupuytren(FR)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Nutrition, Genetics, and Disease, Ovarian cancer diagnosis and treatment
Most-Cited Works
- → A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma(2011)515 cited
- → Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial(2022)291 cited
- → Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer(2018)167 cited
- → Impact of body composition on outcome in patients with early breast cancer(2017)156 cited
- → 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial(2019)126 cited
- → Abstract PD8-02: Trastuzumab deruxtecan (T-DXd) for advanced breast cancer patients (ABC), regardless HER2 status: A phase II study with biomarkers analysis (DAISY)(2022)107 cited